| 04/30/2026 10:57 AM | Protagonist Therapeutics (1377121) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 1:43 PM | Protagonist Therapeutics (1377121) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/28/2026 3:54 PM | Protagonist Therapeutics (1377121) Filer | Form ARS | |
| 04/28/2026 3:44 PM | Protagonist Therapeutics (1377121) Filer | Form DEF 14A | |
| 04/28/2026 3:50 PM | Protagonist Therapeutics (1377121) Filer | Form DEFA14A | |
| 04/21/2026 3:57 PM | Ali Asif (1921163) Reporting Protagonist Therapeutics (1377121) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/21/2026 3:58 PM | Ali Asif (1921163) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 6:34 PM | Protagonist Therapeutics (1377121) Issuer SELICK HAROLD E (1287233) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 6:36 PM | MOLINA ARTURO MD (1398940) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 6:33 PM | Ali Asif (1921163) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 10:33 AM | Protagonist Therapeutics (1377121) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for PTGX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/25/2026 6:23 PM | PATEL DINESH V PH D (1120477) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:56 PM | PATEL DINESH V PH D (1120477) Reporting Protagonist Therapeutics (1377121) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/18/2026 5:12 PM | Protagonist Therapeutics (1377121) Issuer Williams Lewis T (1475714) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 4:27 PM | Protagonist Therapeutics (1377121) Subject Williams Lewis T (1475714) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 7:41 AM | Protagonist Therapeutics (1377121) Subject RTW INVESTMENTS, LP (1493215) Filed by | Form SCHEDULE 13G/A | |
| 02/10/2026 10:19 AM | Protagonist Therapeutics (1377121) Subject | Form SCHEDULE 13G | |
| 02/06/2026 3:38 PM | Protagonist Therapeutics (1377121) Issuer Waddill William D. (1553338) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:10 PM | Farallon Capital Partners, L.P. (1175707) Filed by Protagonist Therapeutics (1377121) Subject | Form SCHEDULE 13G/A | |
| 01/30/2026 1:43 PM | Protagonist Therapeutics (1377121) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 01/27/2026 8:19 PM | MOLINA ARTURO MD (1398940) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/27/2026 8:20 PM | Ali Asif (1921163) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/27/2026 8:21 PM | PATEL DINESH V PH D (1120477) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/27/2026 4:12 PM | Ali Asif (1921163) Reporting Protagonist Therapeutics (1377121) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/26/2026 3:29 PM | MOLINA ARTURO MD (1398940) Reporting Protagonist Therapeutics (1377121) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/23/2026 3:06 PM | PATEL DINESH V PH D (1120477) Reporting Protagonist Therapeutics (1377121) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/21/2026 4:15 PM | Ali Asif (1921163) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 4:16 PM | PATEL DINESH V PH D (1120477) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 4:17 PM | MOLINA ARTURO MD (1398940) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 4:10 PM | Ali Asif (1921163) Reporting Protagonist Therapeutics (1377121) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/21/2026 4:11 PM | PATEL DINESH V PH D (1120477) Reporting Protagonist Therapeutics (1377121) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/21/2026 4:12 PM | MOLINA ARTURO MD (1398940) Reporting Protagonist Therapeutics (1377121) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/13/2026 3:45 PM | Protagonist Therapeutics (1377121) Issuer SELICK HAROLD E (1287233) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 7:00 AM | Protagonist Therapeutics (1377121) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/06/2026 6:37 PM | Ali Asif (1921163) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 6:38 PM | PATEL DINESH V PH D (1120477) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 6:39 PM | O'Dowd Sarah A (1447149) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 6:40 PM | Protagonist Therapeutics (1377121) Issuer Williams Lewis T (1475714) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 6:41 PM | Giraudo Bryan (1740847) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 6:42 PM | Protagonist Therapeutics (1377121) Issuer Waddill William D. (1553338) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 6:44 PM | Protagonist Therapeutics (1377121) Issuer SELICK HAROLD E (1287233) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 01/06/2026 6:35 PM | MOLINA ARTURO MD (1398940) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 3:01 PM | MOLINA ARTURO MD (1398940) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/14/2025 7:23 AM | Deep Track Capital, LP (1856083) Filed by Protagonist Therapeutics (1377121) Subject | Form SCHEDULE 13G/A | |
| 11/06/2025 3:52 PM | Protagonist Therapeutics (1377121) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/06/2025 3:19 PM | Protagonist Therapeutics (1377121) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 5:24 PM | BlackRock, Inc. (2012383) Filed by Protagonist Therapeutics (1377121) Subject | Form SCHEDULE 13G/A | |
| 10/14/2025 3:01 PM | Protagonist Therapeutics (1377121) Issuer Waddill William D. (1553338) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/10/2025 3:18 PM | Protagonist Therapeutics (1377121) Subject Waddill William D. (1553338) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/24/2025 7:35 PM | Protagonist Therapeutics (1377121) Issuer Waddill William D. (1553338) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2025 4:35 PM | PATEL DINESH V PH D (1120477) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/29/2025 4:30 PM | Protagonist Therapeutics (1377121) Issuer Waddill William D. (1553338) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/27/2025 3:33 PM | Protagonist Therapeutics (1377121) Subject Waddill William D. (1553338) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/11/2025 7:04 AM | Protagonist Therapeutics (1377121) Subject STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by | Form SCHEDULE 13G | |
| 07/28/2025 5:08 PM | PATEL DINESH V PH D (1120477) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/23/2025 5:57 PM | PATEL DINESH V PH D (1120477) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/26/2025 3:08 PM | Protagonist Therapeutics (1377121) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2025 4:30 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by Protagonist Therapeutics (1377121) Subject | Form SCHEDULE 13G | |
| 06/11/2025 4:40 PM | MOLINA ARTURO MD (1398940) Reporting Protagonist Therapeutics (1377121) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2025 4:51 PM | MOLINA ARTURO MD (1398940) Reporting Protagonist Therapeutics (1377121) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/09/2025 3:46 PM | MOLINA ARTURO MD (1398940) Reporting Protagonist Therapeutics (1377121) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/13/2025 11:10 AM | Protagonist Therapeutics (1377121) Subject STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by | Form SCHEDULE 13G | |
| 05/06/2025 3:27 PM | Protagonist Therapeutics (1377121) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |